news
Old lipid drug TOFA boosts metabolism, shows obesity potential.
New research in *Science Advances* identifies 5-tetradecyloxy-2-furoic acid (TOFA), a 1970s lipid-lowering compound, as a potential obesity treatment. The study found TOFA boosts metabolic rate, suggesting a pathway to address insulin resistance and abnormal blood lipid levels. This could mean a new chemical approach to a persistent problem.
New research in Science Advances identifies 5-tetradecyloxy-2-furoic acid (TOFA), a 1970s lipid-lowering compound, as a potential obesity treatment. The study found TOFA boosts metabolic rate, suggesting a pathway to address insulin resistance and abnormal blood lipid levels. This could mean a new chemical approach to a persistent problem.
The architecture take
I keep seeing these old drugs repurposed, and it makes me wonder what else is hiding in dusty pharmacy archives. This one, TOFA, is from the 70s and used to lower lipids. Now, it looks like it flips a switch in your metabolism, helping your body burn more energy. The researchers found it boosts metabolic rate, which is a pretty direct way to tackle weight gain, rather than just curbing appetite. That's a different angle than the GLP-1s, and it's intriguing. What happens when you combine these mechanisms? The body has so many redundant systems that can be poked. This isn't about some fancy new molecule; it's about re-evaluating what we already have. It shows how much we still don't fully understand about basic metabolic function, and how a simple compound can nudge it in surprising ways. Pay attention to how this plays with existing treatments.